2027 年亚太地区切片机市场预测 - COVID-19 影响和按产品划分的区域分析(切片机仪器、切片机配件);技术(手动切片机、半自动切片机、全自动切片机);最终用户(医院、临床实验室、其他最终用户)

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 125    |    Report Code: TIPRE00013020    |    Category: Life Sciences

Asia Pacific Microtome Market

市场介绍

切片机是一种切割组织部分的设备,切割薄片的过程称为切片术。使用适当的染色方法对这些切片进行染色,然后在显微镜下观察它们。不同品种的切片机用于对石蜡、塑料包埋组织进行切片,以及用于对冷冻组织进行切片的特定切片机。

市场概况和动态

span>

亚太切片机市场预计将从 2019 年的 24,937.2 万美元增至 2027 年的 40,16.06 万美元。该市场预计将以2020 年至 2027 年复合年增长率为 6.3%。推动市场增长的因素包括癌症患病率上升以及数字病理学的日益采用。然而,由于低收入国家缺乏采用,市场可能会产生负面影响。

关键细分市场

从产品来看,切片机仪器领域在 2019 年占据了最大的市场份额;此外,预计同一细分市场在预测期内将实现市场上最高的复合年增长率。就技术而言,全自动切片机细分市场在 2019 年占据了最大的市场份额; 此外,预计该细分市场在来年将以最快的速度增长。在最终用户领域,临床实验室领域占据最大的市场份额。此外,预计该细分市场在来年将以最快的速度增长。

主要来源和上市公司

报告中包含的亚太切片机市场的一些主要主要和次要来源包括世界卫生组织 (WHO)、国家宫颈癌联盟、国家乳腺癌和宫颈癌早期检测计划 (NBCCEDP) 等。

购买报告的理由

  • 了解亚太地区切片机市场格局并确定最有可能保证丰厚回报的细分市场
  • 保持领先地位了解亚太切片机市场不断变化的竞争格局
  • 通过识别最有前景的细分市场,有效规划亚太切片机市场的并购和合作交易销售
  • 通过对亚太切片机市场各个细分市场的市场表现进行敏锐而全面的分析,帮助做出明智的业务决策
  • 获取亚太地区各细分市场2019年至2027年的市场收入预测。

< /strong>

 

亚太切片机市场 -

作者

产品

  • 切片机仪器
    • 旋转切片机
    • 低温切片机
    • 振动切片机
    • 其他切片机仪器
  • 切片机配件

按技术

  • 手动切片机
  • 半自动切片机
  • 全自动切片机

最终用户

  • 医院
  • 临床实验室
  • 其他最终用户

国家/地区

  • 中国
  • 日本
  • 印度 span>
  • 澳大利亚
  • 韩国

 < /span>

公司简介

  • PHC Holdings Corporation
  • MEDITE Medical GmbH
  • Leica Biosystems Nussloch GmbH(丹纳赫)
  • Amos Scientific Pty Ltd
  • SM 科学仪器列兵。有限公司


Asia Pacific Microtome Strategic Insights

Strategic insights for Asia Pacific Microtome involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-microtome-market-strategic-framework.webp
Get more information on this report

Asia Pacific Microtome Report Scope

Report Attribute Details
Market size in 2019 US$ 24,937.2 thousand
Market Size by 2027 US$ 40,160.6 thousand
Global CAGR (2020 - 2027) 6.3%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品
  • 切片机仪器
  • 切片机配件
By 技术
  • 手动切片机
  • 半自动切片机
  • 全自动切片机
By 最终用户
  • 医院
  • 临床实验室
  • 其他最终用户
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • PHC Holdings Corporation
  • MEDITE Medical GmbH
  • Leica Biosystems Nussloch GmbH (Danaher)
  • Amos Scientific Pty Ltd
  • SM Scientific Instruments Pvt. Ltd
  • Get more information on this report

    Asia Pacific Microtome Regional Insights

    The regional scope of Asia Pacific Microtome refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-microtome-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Microtome Market

    1. PHC Holdings Corporation
    2. MEDITE Medical GmbH
    3. Leica Biosystems Nussloch GmbH (Danaher)
    4. Amos Scientific Pty Ltd
    5. SM Scientific Instruments Pvt. Ltd
    Frequently Asked Questions
    How big is the Asia Pacific Microtome Market?

    The Asia Pacific Microtome Market is valued at US$ 24,937.2 thousand in 2019, it is projected to reach US$ 40,160.6 thousand by 2027.

    What is the CAGR for Asia Pacific Microtome Market by (2020 - 2027)?

    As per our report Asia Pacific Microtome Market, the market size is valued at US$ 24,937.2 thousand in 2019, projecting it to reach US$ 40,160.6 thousand by 2027. This translates to a CAGR of approximately 6.3% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Microtome Market report typically cover these key segments-

  • 产品 (切片机仪器, 切片机配件)
  • 技术 (手动切片机, 半自动切片机, 全自动切片机)
  • 最终用户 (医院, 临床实验室, 其他最终用户)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Microtome Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Microtome Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Asia Pacific Microtome Market?

    The Asia Pacific Microtome Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • PHC Holdings Corporation
  • MEDITE Medical GmbH
  • Leica Biosystems Nussloch GmbH (Danaher)
  • Amos Scientific Pty Ltd
  • SM Scientific Instruments Pvt. Ltd
  • Who should buy this report?

    The Asia Pacific Microtome Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Microtome Market value chain can benefit from the information contained in a comprehensive market report.